Guess Where Harvard’s Private Equity Will Likely End Up

Imagine an institutional investor that allocates a big chunk of its portfolio to illiquid private assets but then needs to sell some of those investments to raise cash. Or a fund company that makes a fortune on actively managed mutual funds for decades, but its investors move their money to low-cost index trackers. Or a financial research company built around selling ratings of actively managed funds that people no longer buy.

Those may sound like three unrelated problems, but they all have a single solution, apparently: Sell private assets to financial advisers and unsuspecting retail investors.

Harvard University, a standard bearer among institutional investors, relies on its vast $53 billion endowment to fund a significant portion of its operations. The asset rich but cash poor endowment must sell some of its investments occasionally to raise money, and it may have to do so more aggressively now that the Trump administration is blocking grants to the university and alumni are cutting back on donations.

The difficulty is that 40% of Harvard’s endowment is in illiquid private equity, nearly twice its total holding of stocks and bonds. Selling only those liquid stocks and bonds would further raise its already aggressive allocation to private assets, which is probably one reason the endowment is reportedly looking to trim its private equity.

Easier said than done. Private equity is in a funk. Recent returns have been underwhelming, investors are cutting back on new commitments, and Harvard isn’t the only one looking to unload private equity. PE funds have navigated the slowdown mostly by selling their portfolio companies to each other. But the industry can only shuffle money around for so long. Eventually, it will need a new pool of buyers if it wants to exit its investments and continue to grow.